Your browser doesn't support javascript.
loading
External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.
Das, Satya; Chauhan, Aman; Du, Liping; Thomas, Katharine E; Jacob, Aasems; Schad, Aimee; Jain, Shikha; Jessop, Aaron; Shah, Chirayu; Eisner, David; Cardin, Dana B; Ciombor, Kristen K; Goff, Laura W; Bradshaw, Marques; Delbeke, Dominique; Sandler, Martin; Ramirez, Robert A; Berlin, Jordan.
Afiliação
  • Das S; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chauhan A; University of Kentucky Markey Cancer Center, Lexington.
  • Du L; Department of Biostatistics, Vanderbilt University of Medical Center, Nashville, Tennessee.
  • Thomas KE; Division of Hematology and Medical Oncology, Department of Medicine, Lousiana State University, New Orleans.
  • Jacob A; University of Kentucky Markey Cancer Center, Lexington.
  • Schad A; Department of Medicine, Rush Medical Center, Chicago, Illinois.
  • Jain S; Department of Medicine, University of Illinois Chicago, Chicago.
  • Jessop A; Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Shah C; Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Eisner D; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Cardin DB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ciombor KK; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Goff LW; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bradshaw M; Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Delbeke D; Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sandler M; Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ramirez RA; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Berlin J; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Netw Open ; 5(1): e2144170, 2022 01 04.
Article em En | MEDLINE | ID: mdl-35044469

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Índice de Gravidade de Doença / Receptores de Peptídeos / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Índice de Gravidade de Doença / Receptores de Peptídeos / Tumores Neuroendócrinos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article